nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.149	0.167	CbGbCtD
Pyrimethamine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.137	0.154	CbGbCtD
Pyrimethamine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.137	0.154	CbGbCtD
Pyrimethamine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.125	0.141	CbGbCtD
Pyrimethamine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.125	0.141	CbGbCtD
Pyrimethamine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.112	0.126	CbGbCtD
Pyrimethamine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.104	0.117	CbGbCtD
Pyrimethamine—Pulmonary eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.0132	0.288	CcSEcCtD
Pyrimethamine—DHFR—Trans-sulfuration and one carbon metabolism—GCLC—chronic obstructive pulmonary disease	0.00281	0.043	CbGpPWpGaD
Pyrimethamine—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—chronic obstructive pulmonary disease	0.00244	0.0375	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00241	0.037	CbGpPWpGaD
Pyrimethamine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00221	0.0339	CbGpPWpGaD
Pyrimethamine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00205	0.0315	CbGpPWpGaD
Pyrimethamine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00201	0.0308	CbGpPWpGaD
Pyrimethamine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.0018	0.0276	CbGpPWpGaD
Pyrimethamine—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.0376	CcSEcCtD
Pyrimethamine—DHFR—Metabolism of nitric oxide—NOS3—chronic obstructive pulmonary disease	0.00169	0.0259	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00167	0.0256	CbGpPWpGaD
Pyrimethamine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00164	0.0251	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00162	0.0248	CbGpPWpGaD
Pyrimethamine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00161	0.0246	CbGpPWpGaD
Pyrimethamine—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00158	0.0344	CcSEcCtD
Pyrimethamine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.0328	CcSEcCtD
Pyrimethamine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00146	0.0224	CbGpPWpGaD
Pyrimethamine—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00134	0.0292	CcSEcCtD
Pyrimethamine—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.0286	CcSEcCtD
Pyrimethamine—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00131	0.0286	CcSEcCtD
Pyrimethamine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00131	0.02	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.0278	CcSEcCtD
Pyrimethamine—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.027	CcSEcCtD
Pyrimethamine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00119	0.0182	CbGpPWpGaD
Pyrimethamine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.0252	CcSEcCtD
Pyrimethamine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00115	0.025	CcSEcCtD
Pyrimethamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.024	CcSEcCtD
Pyrimethamine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.024	CcSEcCtD
Pyrimethamine—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00106	0.0163	CbGpPWpGaD
Pyrimethamine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.016	CbGpPWpGaD
Pyrimethamine—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00102	0.0157	CbGpPWpGaD
Pyrimethamine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.001	0.0219	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000879	0.0191	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000879	0.0191	CcSEcCtD
Pyrimethamine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000872	0.0134	CbGpPWpGaD
Pyrimethamine—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000864	0.0133	CbGpPWpGaD
Pyrimethamine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000861	0.0188	CcSEcCtD
Pyrimethamine—DHFR—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000852	0.0131	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000851	0.0185	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000843	0.0184	CcSEcCtD
Pyrimethamine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000839	0.0129	CbGpPWpGaD
Pyrimethamine—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000831	0.0127	CbGpPWpGaD
Pyrimethamine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00083	0.0181	CcSEcCtD
Pyrimethamine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000802	0.0175	CcSEcCtD
Pyrimethamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000791	0.0172	CcSEcCtD
Pyrimethamine—DHFR—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.00078	0.012	CbGpPWpGaD
Pyrimethamine—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000772	0.0118	CbGpPWpGaD
Pyrimethamine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000757	0.0116	CbGpPWpGaD
Pyrimethamine—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000742	0.0114	CbGpPWpGaD
Pyrimethamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000734	0.016	CcSEcCtD
Pyrimethamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.0157	CcSEcCtD
Pyrimethamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000692	0.0151	CcSEcCtD
Pyrimethamine—DHFR—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000654	0.01	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.000653	0.01	CbGpPWpGaD
Pyrimethamine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000648	0.00993	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000648	0.0141	CcSEcCtD
Pyrimethamine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.0141	CcSEcCtD
Pyrimethamine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000634	0.0138	CcSEcCtD
Pyrimethamine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000634	0.00971	CbGpPWpGaD
Pyrimethamine—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000628	0.00963	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000611	0.0133	CcSEcCtD
Pyrimethamine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000609	0.00934	CbGpPWpGaD
Pyrimethamine—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000604	0.00926	CbGpPWpGaD
Pyrimethamine—DHFR—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000604	0.00926	CbGpPWpGaD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000592	0.00908	CbGpPWpGaD
Pyrimethamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000565	0.00867	CbGpPWpGaD
Pyrimethamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000559	0.0122	CcSEcCtD
Pyrimethamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000559	0.0122	CcSEcCtD
Pyrimethamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000547	0.0119	CcSEcCtD
Pyrimethamine—DHFR—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000532	0.00815	CbGpPWpGaD
Pyrimethamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000528	0.0115	CcSEcCtD
Pyrimethamine—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00051	0.00782	CbGpPWpGaD
Pyrimethamine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000502	0.0077	CbGpPWpGaD
Pyrimethamine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.0104	CcSEcCtD
Pyrimethamine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000471	0.00722	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000451	0.00692	CbGpPWpGaD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000441	0.00676	CbGpPWpGaD
Pyrimethamine—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000435	0.00667	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000415	0.00637	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000386	0.00591	CbGpPWpGaD
Pyrimethamine—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000371	0.00568	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00037	0.00568	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000367	0.00563	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.00555	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APIP—chronic obstructive pulmonary disease	0.000359	0.00551	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000359	0.0055	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000358	0.00548	CbGpPWpGaD
Pyrimethamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000357	0.00548	CbGpPWpGaD
Pyrimethamine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000354	0.00543	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.00764	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000346	0.00754	CcSEcCtD
Pyrimethamine—DHFR—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.00034	0.00521	CbGpPWpGaD
Pyrimethamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00033	0.00718	CcSEcCtD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00032	0.00491	CbGpPWpGaD
Pyrimethamine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000316	0.00485	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000311	0.00477	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000302	0.00463	CbGpPWpGaD
Pyrimethamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00655	CcSEcCtD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000294	0.0045	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.00446	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000273	0.00418	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00403	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000261	0.004	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.00398	CbGpPWpGaD
Pyrimethamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.00398	CbGpPWpGaD
Pyrimethamine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.00395	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00555	CcSEcCtD
Pyrimethamine—DHFR—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000238	0.00365	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GC—chronic obstructive pulmonary disease	0.000231	0.00355	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000229	0.0035	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000226	0.00346	CbGpPWpGaD
Pyrimethamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00479	CcSEcCtD
Pyrimethamine—DHFR—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000215	0.0033	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00327	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.00324	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00019	0.00291	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000188	0.00288	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.00287	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000186	0.00285	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000185	0.00284	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000184	0.00282	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000161	0.00246	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000158	0.00243	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000156	0.0024	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00239	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.00237	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00236	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00234	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000146	0.00223	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000144	0.0022	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00212	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00209	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000131	0.002	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00013	0.00199	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000129	0.00198	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000128	0.00197	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000127	0.00195	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HDAC2—chronic obstructive pulmonary disease	0.000127	0.00195	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000126	0.00194	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000125	0.00192	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00012	0.00183	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000118	0.00182	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KL—chronic obstructive pulmonary disease	0.000118	0.00181	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000118	0.00181	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000117	0.00179	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000114	0.00175	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00174	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00172	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00171	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000111	0.0017	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.0017	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00161	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	9.11e-05	0.0014	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	9.04e-05	0.00139	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ERBB3—chronic obstructive pulmonary disease	8.84e-05	0.00136	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.77e-05	0.00134	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.65e-05	0.00133	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.06e-05	0.00123	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.92e-05	0.00121	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.00117	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOS2—chronic obstructive pulmonary disease	7.37e-05	0.00113	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.35e-05	0.00113	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.29e-05	0.00112	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	7.15e-05	0.0011	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.65e-05	0.00102	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.44e-05	0.000988	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TP53—chronic obstructive pulmonary disease	6.29e-05	0.000965	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SERPINE1—chronic obstructive pulmonary disease	6.21e-05	0.000952	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.04e-05	0.000926	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.99e-05	0.000918	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.94e-05	0.00091	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOS3—chronic obstructive pulmonary disease	5.93e-05	0.000909	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	5.87e-05	0.0009	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	5.82e-05	0.000893	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.46e-05	0.000837	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.41e-05	0.00083	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.000812	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—chronic obstructive pulmonary disease	5.19e-05	0.000796	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NOS3—chronic obstructive pulmonary disease	4.97e-05	0.000761	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.000661	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—chronic obstructive pulmonary disease	3.92e-05	0.000601	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.91e-05	0.000599	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.86e-05	0.000592	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGFR—chronic obstructive pulmonary disease	3.84e-05	0.000589	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.6e-05	0.000552	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.53e-05	0.00054	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.25e-05	0.000498	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.21e-05	0.000492	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.18e-05	0.000488	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.17e-05	0.000486	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.14e-05	0.000482	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—chronic obstructive pulmonary disease	2.95e-05	0.000453	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.93e-05	0.000449	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.89e-05	0.000444	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.87e-05	0.00044	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.71e-05	0.000415	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.67e-05	0.00041	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.000409	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.64e-05	0.000405	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.49e-05	0.000382	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.36e-05	0.000362	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.22e-05	0.000341	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.2e-05	0.000338	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.19e-05	0.000336	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.17e-05	0.000333	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.04e-05	0.000313	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.03e-05	0.000311	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	0.000297	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.000294	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000246	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.53e-05	0.000235	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-05	0.000202	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.31e-05	0.0002	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-05	0.000193	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.25e-05	0.000191	CbGpPWpGaD
